A detailed history of Bellevue Group Ag transactions in Pfizer Inc stock. As of the latest transaction made, Bellevue Group Ag holds 141,075 shares of PFE stock, worth $3.75 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
141,075
Previous 88,614 59.2%
Holding current value
$3.75 Million
Previous $2.48 Million 64.66%
% of portfolio
0.07%
Previous 0.04%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$27.7 - $31.39 $1.45 Million - $1.65 Million
52,461 Added 59.2%
141,075 $4.08 Million
Q2 2024

Aug 14, 2024

BUY
$25.26 - $29.6 $1.38 Million - $1.62 Million
54,780 Added 161.91%
88,614 $2.48 Million
Q1 2024

May 15, 2024

BUY
$25.89 - $29.73 $283,909 - $326,019
10,966 Added 47.95%
33,834 $938,000
Q4 2023

Feb 14, 2024

BUY
$26.13 - $33.94 $347,868 - $451,843
13,313 Added 139.33%
22,868 $658,000
Q3 2023

Nov 14, 2023

BUY
$32.09 - $37.51 $306,619 - $358,408
9,555 New
9,555 $316,000
Q1 2023

May 15, 2023

SELL
$39.39 - $51.28 $1.89 Million - $2.46 Million
-47,978 Reduced 6.08%
740,695 $30.2 Million
Q4 2022

Feb 14, 2023

BUY
$41.75 - $54.5 $892,322 - $1.16 Million
21,373 Added 2.79%
788,673 $40.4 Million
Q3 2022

Nov 14, 2022

SELL
$43.76 - $53.42 $2.99 Million - $3.65 Million
-68,384 Reduced 8.18%
767,300 $33.6 Million
Q2 2022

Aug 11, 2022

BUY
$46.53 - $55.17 $36.7 Million - $43.5 Million
789,184 Added 1697.17%
835,684 $43.8 Million
Q1 2022

May 13, 2022

SELL
$45.75 - $56.69 $3.04 Million - $3.77 Million
-66,500 Reduced 58.85%
46,500 $2.41 Million
Q4 2021

Feb 10, 2022

BUY
$41.32 - $61.25 $553,688 - $820,750
13,400 Added 13.45%
113,000 $6.67 Million
Q3 2021

Nov 12, 2021

BUY
$39.25 - $50.42 $3.91 Million - $5.02 Million
99,600 New
99,600 $4.28 Million
Q1 2021

May 12, 2021

SELL
$33.49 - $37.77 $2.47 Million - $2.79 Million
-73,900 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$31.75 - $37.25 $2.35 Million - $2.75 Million
73,900 New
73,900 $2.71 Million
Q2 2020

Aug 13, 2020

SELL
$30.12 - $36.54 $2.71 Million - $3.29 Million
-90,000 Closed
0 $0
Q1 2020

May 14, 2020

BUY
$27.03 - $38.62 $810,900 - $1.16 Million
30,000 Added 50.0%
90,000 $2.94 Million
Q4 2019

Feb 14, 2020

BUY
$32.92 - $37.36 $658,400 - $747,200
20,000 Added 50.0%
60,000 $2.35 Million
Q1 2019

May 15, 2019

BUY
$37.5 - $41.2 $1.5 Million - $1.65 Million
40,000 New
40,000 $1.7 Million
Q4 2018

Feb 12, 2019

SELL
$38.47 - $43.86 $1.12 Million - $1.28 Million
-29,200 Closed
0 $0
Q2 2017

Aug 14, 2017

BUY
N/A
29,200
29,200 $981,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $149B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Bellevue Group Ag Portfolio

Follow Bellevue Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bellevue Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Bellevue Group Ag with notifications on news.